Book expert IFU and label QA proofreading online. Compare vetted specialists for EU MDR/IVDR, FDA, and multi-market IFU compliance review with instant per-document pricing.
✓ 9 active providers available right now· USD 166 – 413
Why this page is different
Instant pricing: See a price estimate immediately (no back-and-forth RFQ needed for these services).
Compare before booking: Review inclusions, exclusions, turnaround, and communication channels.
Charged only when accepted: You are charged only after a provider accepts your order and scope.
Live availability: 9 active providers available right now for this service.
What you can compare here
Total price: See live price ranges and instant pricing rules where available.
Coverage & scope: Markets served, what is included, and what is explicitly excluded.
SLA & responsiveness: Acceptance SLAs and typical turnaround windows.
Add-ons: Optional extras you can book next (shown as add-on chips).
Onboarding time: How quickly providers can start and what you need to supply.
Compare providers (instant pricing + book)
Provider
Estimated base price
Accept SLA
Turnaround
Start
Northgate Regulatory Partners
USD 166
24h
3–5 days
Within 2 business days
Sterling Label & Compliance
USD 270
24h
3–5 days
Within 2 business days
Apex Medical Device Support
USD 413
24h
3–5 days
Within 2 business days
Belmont Regulatory Services
USD 270
24h
3–5 days
Within 2 business days
Summit Device Compliance
USD 413
24h
3–5 days
Within 2 business days
Estimates are derived from each provider’s published pricing rules (and may vary by your inputs).
What affects pricing
These are the inputs providers use to price your order. Enter them once, then compare providers and book instantly.
Submit your IFU, eIFU, or label document and specify the applicable regulation and target language(s).
2
Compare QA reviewers with instant pricing
View per-document fees and turnaround from specialists in medical device IFU compliance.
3
Receive your marked-up document and fix list
Your reviewer returns a redlined document with a prioritised list of required and recommended changes.
What must an IFU contain under EU MDR?
EU MDR 2017/745 Annex I Section 23.4 specifies the mandatory content of Instructions for Use (IFU). This includes: the manufacturer's name and address; the device identification (name, model, catalogue number); the intended purpose, indications, and contraindications; known side effects and residual risks; any special skills or training required to use the device safely; assembly and installation instructions; operating procedure; maintenance and calibration requirements; handling and storage conditions; and information about reprocessing if the device is reusable. For Class III implants and active implantable devices, additional requirements apply, including patient implant cards.
eIFU: electronic Instructions for Use under EU MDR
EU Regulation 2021/2226 allows medical device manufacturers to provide IFUs electronically (eIFU) for certain device categories — primarily non-implantable Class IIa, IIb, and III devices intended for professional use only. The eIFU must be accessible via a URL printed on the device label and via a QR code or DataMatrix on the label. The website hosting the eIFU must be available 24/7, maintained in the current version, and must provide a history of all previous versions with dates. Healthcare facilities must be informed that the IFU is provided electronically and must be able to request a paper copy at no charge at any time.
Common IFU failures identified in QA reviews
The most frequently flagged IFU issues in professional QA reviews include: missing mandatory EU MDR elements (especially residual risk summaries and contraindications); failure to list all languages required for the target EU markets; inconsistent device identification between the IFU and the label; missing IFU version number and revision history; warnings that are insufficiently specific or use ambiguous language; and failure to update the IFU when the device's software or indications changed. For eIFUs, common failures include broken QR codes, missing version history on the hosted website, and inaccessible URLs.
IFU translation and linguistic QA requirements
EU MDR requires IFUs to be available in the official language(s) of the EU member states where the device is made available. For pan-EU distribution, this can mean up to 24 official EU languages. Each translated IFU should undergo a linguistic QA review — ideally by a native speaker with medical terminology competence — to verify accuracy, consistency with the source document, and appropriate reading level. For FDA devices, the IFU must be in English; however, if the device is marketed to non-English-speaking populations, FDA may expect translations to be available. ISO 15223-1 symbols can reduce text in IFUs but must be accompanied by a legend in the IFU.
Frequently asked questions
What does an IFU QA review check?
A QA review verifies regulatory mandatory elements (intended purpose, contraindications, safety warnings, sterilization method, shelf life), linguistic accuracy, reading level, and consistency with your device's technical documentation and performance claims.
Is eIFU (electronic IFU) covered?
Yes. Providers can review eIFU content for EU MDR/IVDR Regulation (EU) 2021/2226 compliance, including website accessibility and QR code/URL placement requirements.
How many languages can one provider review?
Language coverage varies. Many providers review English, French, German, Spanish, and Italian. For less common EU languages, confirm language support with individual providers.
Do I need a fresh IFU review for every software update?
Any material change to your device's software, indications, intended use, or safety warnings requires an updated IFU, which should be re-reviewed before release.
How Cruxi Bridge vets providers
✓ Every provider submits regulatory expertise evidence and jurisdictional coverage claims
✓ Providers that go live agree to the Cruxi Bridge Provider Terms including service delivery and accuracy obligations
✓ Payment is held by Cruxi and only released to the provider after service delivery milestones
✓ Buyers can raise a dispute within 30 days — Cruxi reviews and mediates per the platform terms
Prices and provider availability are live and may change. Charged only when a provider accepts your order.
← All services